Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.20 | N/A |
| PEG Ratio (TTM) | 1.00 | N/A |
| P/S Ratio (TTM) | 1.15 | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | 31.58 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.01 | N/A |
| Price to 5YR AVG FCF Ratio | 112.56 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.64% | N/A |
| ROE (TTM) | 4.58% | N/A |
| Net Profit Margin (TTM) | 3.82% | N/A |
| ROIC 5YR AVG | 4.07% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 34.18% | 200.67% | 94.32% |
| Revenue | 0.67% | 1.48% | 4.21% |
| Net Income | 34.31% | 204.58% | 98.06% |
| Cash Flow | 147.91% | -56.47% | 1,141.95% |
Health (58%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.21 | N/A |
| Quick Ratio (TTM) | 2.16 | N/A |
| D/E Ratio (TTM) | 0.39 | N/A |
| Interest Coverage (TTM) | 3.22 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.97 | N/A |
| LTL to 5YR AVG FCF | 35.03 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.90% | N/A |